Search research articles
Contact Us
Filters
Showing results (131-140 of 262) with videos related to
Page
of 27
Sort By:
International Journal of Molecular Sciences
|
September 23, 2022
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and Subtyping
Stefanie A Köhler, Lisa Brandl, Pamela L Strissel, et al.
Cancers
|
January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
Amer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
International Journal of Molecular Sciences
|
October 29, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8
Elias A T Koch, Renato Liguori, Alejandro Afonso Castro, et al.
Cell Death & Disease
|
February 26, 2020
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
Pablo Lindner, Sushmita Paul, Markus Eckstein, et al.
Frontiers in Oncology
|
November 30, 2020
Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors
Philipp Schubert, Sandra Rutzner, Markus Eckstein, et al.
Nature Communications
|
August 4, 2025
A multimodal dataset for precision oncology in head and neck cancer
Marion Dörrich, Matthias Balk, Tatjana Heusinger, et al.
Translational Oncology
|
March 5, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts
Danijel Sikic, Ralph M Wirtz, Sven Wach, et al.
Life (Basel, Switzerland)
|
July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
Danijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Urologic Oncology
|
July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Danijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
European Urology
|
September 3, 2024
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology
Sandy Figiel, Anthony Bates, David A Braun, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 262) with videos related to
Sort By:
Page
of 27
International Journal of Molecular Sciences
|
September 23, 2022
Improved Bladder Tumor RNA Isolation from Archived Tissues Using Methylene Blue for Normalization, Multiplex RNA Hybridization, Sequencing and Subtyping
Stefanie A Köhler, Lisa Brandl, Pamela L Strissel, et al.
Cancers
|
January 1, 2020
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients
Amer Abdulrahman, Markus Eckstein, Rudolf Jung, et al.
International Journal of Molecular Sciences
|
October 29, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8
Elias A T Koch, Renato Liguori, Alejandro Afonso Castro, et al.
Cell Death & Disease
|
February 26, 2020
EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells
Pablo Lindner, Sushmita Paul, Markus Eckstein, et al.
Frontiers in Oncology
|
November 30, 2020
Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors
Philipp Schubert, Sandra Rutzner, Markus Eckstein, et al.
Nature Communications
|
August 4, 2025
A multimodal dataset for precision oncology in head and neck cancer
Marion Dörrich, Matthias Balk, Tatjana Heusinger, et al.
Translational Oncology
|
March 5, 2019
Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts
Danijel Sikic, Ralph M Wirtz, Sven Wach, et al.
Life (Basel, Switzerland)
|
July 2, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
Danijel Sikic, Helge Taubert, Ralph M Wirtz, et al.
Urologic Oncology
|
July 31, 2021
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Danijel Sikic, Markus Eckstein, Veronika Weyerer, et al.
European Urology
|
September 3, 2024
Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology
Sandy Figiel, Anthony Bates, David A Braun, et al.
Page
of 27